AppOmni’s product maturity, roadmap, and flexible approach to onboarding customers impressed the company’s security team. “They definitely stuck out from basically hour one,” the security leader recalled. ”The immersion into our needs, and what it is we want to do, and which SaaS solutions we wanted to cover, were great from day one. And it’s been a complete success.”
After eliminating several prominent security vendors, including their incumbent providers of the SSE and CASB technologies, that failed to provide full visibility into SaaS systems or flexibility in the implementation, the pharmaceutical company engaged AppOmni in a POC.
Must-have features/capabilities for the global pharmaceutical company include:
- Greater control and visibility into SaaS security configurations and posture, and alerts for configuration drift
- Visibility into user access rights and behavior across SaaS applications
- Full coverage for Salesforce, Veeva Vault, and Microsoft 365
- Modern technology stack for securing SaaS, rather than a CASB solution with limited SaaS security capabilities beyond the network level
- Complete audit trails to maintain the company’s GxP and FDA compliance
- High degree of customizability and flexibility with implementation
“Functionality-wise, AppOmni was way beyond what everybody else could do,” the pharmaceutical leader shared. “From a technical point of view, there was no discussion.”
AppOmni’s Impact
Complete visibility into the entire SaaS estate, including user access and behavior
Ability to vet, configure, and maintain security for new SaaS systems
Easy administration and change management with an intuitive user interface
Maintained compliance with GxP and FDA regulations
SaaS Security After AppOmni
With AppOmni in place, the company’s security team no longer wonders about the implications of 300 new security controls when a SaaS vendor launches a new release. By simplifying SaaS security complexity, the pharmaceutical security team can now focus on critical security controls that significantly reduce cyber risk throughout their SaaS environment.
Alerts for new configurations or configuration drift — complete with actionable guidance that reflects the company’s IT and security policies — are delivered automatically to the right security team members. With complete visibility into configuration management, access rights, and user behavior, the pharmaceutical security team has achieved the zero trust relationship with SaaS vendors it desired. Plus, comprehensive audit logs and a robust policy library maintain GxP and FDA compliance.
With the proper SaaS security framework in place, the company is confident in its ability to evaluate and secure additional SaaS vendors.
“The AppOmni platform itself has all the things we need, has all the integrations we need, from day one,” the company’s security leader summarized. “It’s an easy tool to work with. It’s responsive, and it’s just how it should be. We have great support, and my technical team is extremely happy with it.”
Latest Research and Publications
-
How AppOmni and Cisco Advance Zero Trust SaaS Security
Learn how AppOmni’s SSPM and Cisco’s SSE create a unified Zero Trust security solution, bridging SaaS and cloud service vulnerabilities to protect critical data.
-
What 2024’s SaaS Breaches Mean for 2025 Cybersecurity
In this blog, we take a look at the most impactful SaaS security incidents in 2024 and share insights on what to expect in 2025 for SaaS security.
-
Microsoft Power Pages: Data Exposure Reviewed
Learn about a data exposure risk in Microsoft Power Pages due to misconfigured access controls, highlighting the need for better security and monitoring.